WS #12008

From 500 msgs · 4 key-dev

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, a significant catalyst for BIIB.

FDA Approval for Biogen Alzheimer's Drug

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, a significant catalyst for BIIB.

Full world state #12008 →

FDA Approval for Biogen Alzheimer's Drug — World state #12008 · River